When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases

被引:6
作者
Boi, Dalila [1 ]
Rubini, Elisabetta [1 ]
Breccia, Sara [1 ]
Guarguaglini, Giulia [2 ]
Paiardini, Alessandro [1 ]
机构
[1] Sapienza Univ Rome, Dept Biochem Sci, I-00185 Rome, Italy
[2] Sapienza Univ Rome, Inst Mol Biol & Pathol, Natl Res Council Italy, I-00185 Rome, Italy
关键词
Myc; kinases; PLK1; Aurora-A; Aurora-B; GSK-3; PKA; PIM; BRD4; kinase inhibitors; AURORA-B KINASE; NEUROENDOCRINE PROSTATE-CANCER; CHROMOSOMAL PASSENGER COMPLEX; REGULATES C-MYC; PHASE-II TRIAL; PIM KINASE; N-MYC; CATALYTIC SUBUNIT; STRUCTURAL BASIS; OPEN-LABEL;
D O I
10.3390/ijms24054746
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myc transcription factors are key regulators of many cellular processes, with Myc target genes crucially implicated in the management of cell proliferation and stem pluripotency, energy metabolism, protein synthesis, angiogenesis, DNA damage response, and apoptosis. Given the wide involvement of Myc in cellular dynamics, it is not surprising that its overexpression is frequently associated with cancer. Noteworthy, in cancer cells where high Myc levels are maintained, the overexpression of Myc-associated kinases is often observed and required to foster tumour cells' proliferation. A mutual interplay exists between Myc and kinases: the latter, which are Myc transcriptional targets, phosphorylate Myc, allowing its transcriptional activity, highlighting a clear regulatory loop. At the protein level, Myc activity and turnover is also tightly regulated by kinases, with a finely tuned balance between translation and rapid protein degradation. In this perspective, we focus on the cross-regulation of Myc and its associated protein kinases underlying similar and redundant mechanisms of regulation at different levels, from transcriptional to post-translational events. Furthermore, a review of the indirect effects of known kinase inhibitors on Myc provides an opportunity to identify alternative and combined therapeutic approaches for cancer treatment.
引用
收藏
页数:35
相关论文
共 264 条
[1]   PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase [J].
Adhikari, Bikash ;
Bozilovic, Jelena ;
Diebold, Mathias ;
Schwarz, Jessica Denise ;
Hofstetter, Julia ;
Schroeder, Martin ;
Wanior, Marek ;
Narain, Ashwin ;
Vogt, Markus ;
Dudvarski Stankovic, Nevenka ;
Baluapuri, Apoorva ;
Schoenemann, Lars ;
Eing, Lorenz ;
Bhandare, Pranjali ;
Kuster, Bernhard ;
Schlosser, Andreas ;
Heinzlmeir, Stephanie ;
Sotriffer, Christoph ;
Knapp, Stefan ;
Wolf, Elmar .
NATURE CHEMICAL BIOLOGY, 2020, 16 (11) :1179-+
[2]   Transcriptional regulation and transformation by MYC proteins [J].
Adhikary, S ;
Eilers, M .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (08) :635-645
[3]   MYC in Oncogenesis and as a Target for Cancer Therapies [J].
Albihn, Ami ;
Johnsen, John Inge ;
Henriksson, Marie Arsenian .
ADVANCES IN CANCER RESEARCH, VOL 107, 2010, 107 :163-224
[4]   Dual-activity PI3K-BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis [J].
Andrews, Forest H. ;
Singh, Alok R. ;
Joshi, Shweta ;
Smith, Cassandra A. ;
Morales, Guillermo A. ;
Garlich, Joseph R. ;
Durden, Donald L. ;
Kutateladze, Tatiana G. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (07) :E1072-E1080
[5]   A review on PIM kinases in tumors [J].
Arrouchi, Housna ;
Lakhlili, Wiame ;
Ibrahimi, Azeddine .
BIOINFORMATION, 2019, 15 (01) :40-45
[6]   The Aurora-A/TPX2 complex: A novel oncogenic holoenzyme? [J].
Asteriti, Italia Anna ;
Rensen, Wilhelmina Maria ;
Lindon, Catherine ;
Lavia, Patrizia ;
Guarguaglini, Giulia .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1806 (02) :230-239
[7]   An open-label, phase II study of the polo-like kinase-1 (P1k-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC) [J].
Awad, Mark M. ;
Chu, Quincy S-C ;
Gandhi, Leena ;
Stephenson, Joe J. ;
Govindan, Ramaswamy ;
Bradford, Daniel S. ;
Bonomi, Philip D. ;
Ellison, David M. ;
Eaton, Keith D. ;
Fritsch, Holger ;
Munzert, Gerd ;
Johnson, Bruce E. ;
Socinski, Mark A. .
LUNG CANCER, 2017, 104 :126-130
[8]   BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC [J].
Ba, Mingchen ;
Long, Hui ;
Yan, Zhaofei ;
Wang, Shuai ;
Wu, Yinbing ;
Tu, Yinuo ;
Gong, Yuanfeng ;
Cui, Shuzhong .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (01) :973-982
[9]   c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover [J].
Bahram, F ;
von der Lehr, N ;
Cetinkaya, C ;
Larsson, LG .
BLOOD, 2000, 95 (06) :2104-2110
[10]   THE HUMAN C-MYC-ONCOGENE - STRUCTURAL CONSEQUENCES OF TRANSLOCATION INTO THE IGH LOCUS IN BURKITT-LYMPHOMA [J].
BATTEY, J ;
MOULDING, C ;
TAUB, R ;
MURPHY, W ;
STEWART, T ;
POTTER, H ;
LENOIR, G ;
LEDER, P .
CELL, 1983, 34 (03) :779-787